NDDO

NDDO Oncology was a premier Contract Research Organization (CRO) specializing in early-phase oncology drug development. Headquartered in Amsterdam, the company originated from the New Drug Development Office of the European Organisation for Research and Treatment of Cancer (EORTC). It provided comprehensive services including clinical trial design, regulatory consultancy, and project management for Phase I and Phase II oncology programs. The organization was highly regarded for its scientific expertise and its ability to bridge the gap between laboratory research and clinical application. In January 2005, NDDO Oncology was acquired by Quintiles Transnational (now IQVIA) to enhance its specialized oncology service offerings.